News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

iBio to Participate in Upcoming Investor Conferences

iBio (NYSE:IBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $5.00 price target on the stock.

iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update

iBio Announces $26 Million Private Placement

iBio (NASDAQ:IBIO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.

Form SCHEDULE 13G/A iBio, Inc. Filed by: ADAR1 Capital Management, LLC

Form SCHEDULE 13G/A iBio, Inc. Filed by: Logos Global Management LP

Form SCHEDULE 13G/A iBio, Inc. Filed by: Lynx1 Capital Management LP

Form 10-Q iBio, Inc. For: Dec 31

Form 8-K iBio, Inc. For: Feb 10

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}